Study of Metformin Overdose

Central Hospital, Nancy, France50 enrolled

Overview

The objective of the METINFO study is an observational single-center retrospective and descriptive study. The main objective is to estimate the real mortality rate associated to a Metformin overdose. Second objectives are to estimate the real hospitalization rate related to metformin overdose and to identify the risk factors of a metformin overdose and especially the potential correlation between metformin blood concentration and overdose severity.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Metformin Associated Lactic Acidosis

Interventions

MetforminDRUG

Level of Metformin blood concentration

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients benifiting of a metformin blood concentration determination in the period ranging from the 1st of July 2019 and the 1st of July 2021. Exclusion Criteria: None.

Locations (1)

University Hospital of Nancy

Vandœuvre-lès-Nancy, France

RECRUITING

Outcomes

Primary Outcomes

Estimation of Mortality Rate

Time frame: 2 years

Secondary Outcomes

Estimation of Hospitalization Rate

Time frame: 2 years

Identification of Risk Factors

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.